← FDA Drug Approvals (Drugs@FDA)

TOFACITINIB CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2026-06-25

Drug application

FDA Application #

ANDA220972

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOFACITINIB CITRATE

Generic name

TOFACITINIB CITRATE

Active ingredients

TOFACITINIB CITRATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

SCIEGEN PHARMS

Manufacturer

ScieGen Pharmaceuticals, INC.

First approval

2026-06-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown